Literature DB >> 24225940

Prevalence and characteristics in coding, classification and diagnosis of diabetes in primary care.

Samuel Seidu1, Melanie J Davies, Samiul Mostafa, Simon de Lusignan, Kamlesh Khunti.   

Abstract

INTRODUCTION: Approximately 366 million people worldwide live with diabetes and this figure is expected to rise. Among the correct diagnosis, there will be errors in the diagnosis, classification and coding, resulting in adverse health and financial implications. AIM: To determine the prevalence and characteristics of diagnostic errors in people with diabetes managed in primary care settings.
METHODS: We conducted a cross-sectional study in nine general practices in Leicester, UK, from May to August 2011, using a validated electronic toolkit. Searches identified cases with potential errors which were manually checked for accuracy.
RESULTS: There were 54 088 patients and 2434 (4.5%) diagnosed with diabetes. Out of 316 people identified with potential errors with the toolkit, 180 (57%) had confirmed errors after manually reviewing the records, resulting in an error prevalence of 7.4%. Correctly coded people on registers had significantly greater glycated haemoglobin (HbA1c) reductions. There were no significant differences between patients with and without errors in their HbA1C, body mass index, age and size of practice. There was also no significant association of the errors with pay-for-performance initiatives; however, those patients not on disease register had worse glycaemic control.
CONCLUSIONS: A high prevalence of diabetic diagnostic errors was confirmed using medication, biochemical and demographic data. Larger studies are needed to more accurately assess the scale of this problem. Automation of these processes might be possible, which would allow searches to be even more user friendly.

Entities:  

Keywords:  DIABETES & ENDOCRINOLOGY

Mesh:

Substances:

Year:  2013        PMID: 24225940     DOI: 10.1136/postgradmedj-2013-132068

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017.

Authors:  Helen J Curtis; John M Dennis; Beverley M Shields; Alex J Walker; Seb Bacon; Andrew T Hattersley; Angus G Jones; Ben Goldacre
Journal:  Diabetes Obes Metab       Date:  2018-06-05       Impact factor: 6.577

2.  Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017.

Authors:  John M Dennis; William E Henley; Andrew P McGovern; Andrew J Farmer; Naveed Sattar; Rury R Holman; Ewan R Pearson; Andrew T Hattersley; Beverley M Shields; Angus G Jones
Journal:  Diabetes Obes Metab       Date:  2019-04-04       Impact factor: 6.577

3.  Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase II.

Authors:  Timothy M E Davis; Wendy Davis
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03

4.  REMISSION OF LONGSTANDING INSULIN-TREATED DIABETES MELLITUS FOLLOWING SURGICAL RESECTION OF PHEOCHROMOCYTOMA.

Authors:  Owain M Leng; Asgar C Madathil
Journal:  AACE Clin Case Rep       Date:  2019-01-30

5.  Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus.

Authors:  Susan E Spratt; Katherine Pereira; Bradi B Granger; Bryan C Batch; Matthew Phelan; Michael Pencina; Marie Lynn Miranda; Ebony Boulware; Joseph E Lucas; Charlotte L Nelson; Benjamin Neely; Benjamin A Goldstein; Pamela Barth; Rachel L Richesson; Isaretta L Riley; Leonor Corsino; Eugenia R McPeek Hinz; Shelley Rusincovitch; Jennifer Green; Anna Beth Barton; Carly Kelley; Kristen Hyland; Monica Tang; Amanda Elliott; Ewa Ruel; Alexander Clark; Melanie Mabrey; Kay Lyn Morrissey; Jyothi Rao; Beatrice Hong; Marjorie Pierre-Louis; Katherine Kelly; Nicole Jelesoff
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

Review 6.  Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature.

Authors:  Beverley M Shields; Jaime L Peters; Chris Cooper; Jenny Lowe; Bridget A Knight; Roy J Powell; Angus Jones; Christopher J Hyde; Andrew T Hattersley
Journal:  BMJ Open       Date:  2015-11-02       Impact factor: 2.692

7.  Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis.

Authors:  Shang-Ming Zhou; Fabiola Fernandez-Gutierrez; Jonathan Kennedy; Roxanne Cooksey; Mark Atkinson; Spiros Denaxas; Stefan Siebert; William G Dixon; Terence W O'Neill; Ernest Choy; Cathie Sudlow; Sinead Brophy
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

8.  Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes.

Authors:  Lauren R Rodgers; Michael N Weedon; William E Henley; Andrew T Hattersley; Beverley M Shields
Journal:  BMJ Open       Date:  2017-10-12       Impact factor: 2.692

9.  Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study.

Authors:  Fatma Rustem Gulluoglu; Patrick C Souverein; Hendrika A van den Ham; Anthonius de Boer; Joris Komen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-12-24       Impact factor: 2.890

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.